MDXR Medical Exercise Inc.
Fundamentals / CIK 0002001249 / USDMedical Exercise Inc. reported $17K in total assets and a net loss of $209K through March 31, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MDXR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Mar 31, 2026
-
Operating Income FY 2026-$205K Operating profit
-
Net Income FY 2026-$209K GAAP bottom line
-
Diluted EPS FY 2026-$0.02 Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$3.1K Total debt: --
Annual revenue and net income
2 fiscal years (2025 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Mar 31 | Mar 31 |
|---|---|---|
| Revenue | -- | $1.3K |
| Cost of Revenue | -- | $445 |
| Gross Profit | -- | $849 |
| Selling, General & Admin | -- | $176K |
| Total Operating Expenses | $222K | $332K |
| Operating Income | -$222K | -$331K |
| EBITDA | -$214K | -$320K |
| Income Before Tax | -$227K | -$331K |
| Net Income | -$227K | -$331K |
| Basic EPS | -$0.02 | -$0.03 |
| Diluted EPS | -$0.02 | -$0.03 |
| Basic Shares Outstanding | 12.6M | 12.2M |
| Diluted Shares Outstanding | 12.6M | 12.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0K | -- | -- | -- | -- | $0 | $0 | $0 |
| Cost of Revenue | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| Gross Profit | $1.0K | -- | -- | -- | -- | $0 | $0 | $0 |
| Selling, General & Admin | -- | -- | $19K | $76K | $61K | $73K | $33K | $46K |
| Total Operating Expenses | $54K | $42K | $26K | $84K | $70K | $68K | $141K | $62K |
| Operating Income | -$53K | -$42K | -$26K | -$84K | -$70K | -$68K | -$141K | -$62K |
| EBITDA | -$52K | -$41K | -$24K | -$82K | -$67K | -$65K | -$138K | -$59K |
| Income Before Tax | -$53K | -$46K | -$26K | -$85K | -$70K | -$68K | -$141K | -$62K |
| Net Income | -$53K | -$46K | -$26K | -$85K | -$70K | -$68K | -$141K | -$62K |
| Basic EPS | $0.00 | -- | -- | -$0.01 | -$0.01 | -- | -$0.01 | -$0.01 |
| Diluted EPS | $0.00 | -- | -- | -$0.01 | -$0.01 | -- | -$0.01 | -$0.01 |
| Basic Shares Outstanding | 13.3M | -- | 12.4M | 12.3M | 12.3M | -- | 12.2M | 12.2M |
| Diluted Shares Outstanding | 13.3M | -- | 12.4M | 12.3M | 12.3M | -- | 12.2M | 12.2M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $43K | $450 | $11K |
| Cash & Short-Term Investments | $43K | $450 | $11K |
| Total Current Assets | $43K | $450 | $11K |
| Property, Plant & Equipment, Net | $16K | $60K | $72K |
| Intangible Assets | $2.0K | $4.9K | $1.9K |
| Total Non-Current Assets | $18K | $65K | $74K |
| Total Assets | $61K | $65K | $85K |
| Deferred Revenue (Current) | $5.9K | $5.9K | $7.0K |
| Other Current Liabilities | $175K | -- | -- |
| Total Current Liabilities | $245K | $133K | $137K |
| Total Non-Current Liabilities | $0 | $0 | $0 |
| Total Liabilities | $245K | $133K | $137K |
| Common Stock | $523K | $412K | $96K |
| Retained Earnings | -$706K | -$479K | -$148K |
| Total Stockholders' Equity | -$184K | -$67K | -$52K |
| Total Equity | -$184K | -$67K | -$52K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.1K | $43K | $41K | $23K | $3.8K | $450 | $11K |
| Cash & Short-Term Investments | $3.1K | $43K | $41K | $23K | $3.8K | $450 | $11K |
| Accounts Receivable, Net | $1.0K | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $14K | $43K | $41K | $23K | $3.8K | $450 | $11K |
| Property, Plant & Equipment, Net | -- | $16K | $40K | $41K | $58K | $60K | $72K |
| Intangible Assets | $2.6K | $2.0K | $5.0K | $4.9K | $5.2K | $4.9K | $1.9K |
| Total Non-Current Assets | $2.6K | $18K | $45K | $46K | $63K | $65K | $74K |
| Total Assets | $17K | $61K | $86K | $70K | $67K | $65K | $85K |
| Deferred Revenue (Current) | $5.9K | $5.9K | $5.9K | $5.9K | $5.9K | $5.9K | $7.0K |
| Other Current Liabilities | $175K | $175K | -- | -- | -- | -- | -- |
| Total Current Liabilities | $253K | $245K | $223K | $281K | $194K | $133K | $137K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $253K | $245K | $223K | $281K | $194K | $133K | $137K |
| Common Stock | $523K | $523K | $523K | $423K | $423K | $412K | $96K |
| Retained Earnings | -$758K | -$706K | -$660K | -$634K | -$549K | -$479K | -$148K |
| Total Stockholders' Equity | -$236K | -$184K | -$138K | -$212K | -$127K | -$67K | -$52K |
| Total Equity | -$236K | -$184K | -$138K | -$212K | -$127K | -$67K | -$52K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Mar 31 | Mar 31 |
|---|---|---|
| Net Income | -$227K | -$331K |
| Depreciation & Amortization | $8.7K | $11K |
| Stock-Based Compensation | $2.0K | $100K |
| Operating Cash Flow | -$195K | -$191K |
| Capital Expenditure | -- | -$3.9K |
| Free Cash Flow | -- | -$195K |
| Investing Cash Flow | $34K | -$5.7K |
| Common Stock Issued | $108K | $16K |
| Financing Cash Flow | $204K | $187K |
| Net Change in Cash | $43K | -$10K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$53K | -$46K | -$26K | -$85K | -$70K | -$68K | -$141K | -$62K |
| Depreciation & Amortization | $542 | $1.7K | $1.9K | $2.2K | $2.9K | $2.8K | $2.9K | $2.9K |
| Stock-Based Compensation | -- | $0 | $0 | $0 | $2.0K | -- | -- | -- |
| Change in Receivables | -$1.0K | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow | -$47K | -$18K | -$77K | -$22K | -$79K | -$47K | -$41K | -$37K |
| Capital Expenditure | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| Free Cash Flow | -- | -- | -- | -- | -- | -$47K | -$41K | -$37K |
| Investing Cash Flow | $6.4K | $22K | -$825 | $14K | -$900 | $0 | -$650 | $3.3K |
| Common Stock Issued | -- | $0 | $100K | $0 | $8.5K | -- | -- | -- |
| Financing Cash Flow | -- | -$1.5K | $95K | $28K | $83K | $39K | $38K | $40K |
| Net Change in Cash | -$40K | $2.9K | $17K | $20K | $3.3K | -$7.5K | -$4.3K | $6.4K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Mar 31 | Mar 31 |
|---|---|---|
| Gross Margin | -- | 65.6% |
| Operating Margin | -- | -25608.5% |
| Net Profit Margin | -- | -25578.4% |
| Return on Assets (ROA) | -369.7% | -507.2% |
| Current Ratio | 0.18x | 0.00x |
| Quick Ratio | 0.18x | 0.00x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | 65.6% | -- | -- |
| Operating Margin | -- | -- | -- | -- | -- | -25608.5% | -- | -- |
| Net Profit Margin | -- | -- | -- | -- | -- | -25578.4% | -- | -- |
| Return on Assets (ROA) | -1250.9% | -369.7% | -290.3% | -523.4% | -511.3% | -507.2% | -- | -- |
| Current Ratio | 0.06x | 0.18x | 0.18x | 0.08x | 0.02x | 0.00x | -- | -- |
| Quick Ratio | 0.02x | 0.18x | 0.18x | 0.08x | 0.02x | 0.00x | -- | -- |